Topiramate Tablet
Product Images NDC 76282-278

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 76282-278). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Kaplan-meier Estimates Of Cumulative Rates For Time To First Seizure (Topiramate Fig1)

A line chart showing cumulative rates for time to first seizure over a period of 500 days in patients taking Topiramate 50 mg/day and 400 mg/day. The graph compares seizure occurrence between the two dosage groups, indicating statistical significance with a p-value of 0.0002.*

FDA Label Image

Table 12: Efficacy Results In Double-blind, Placebo-controlled, Add-on Epilepsy Trials (Topiramate Fig2)

A bar graph comparing the change from baseline to double-blind phase in average monthly migraine rate for placebo and Topiramate dosed at 50 mg/day, 100 mg/day, and 200 mg/day. Two studies (Study 10 and Study 11) are shown for each group, with error bars representing standard error. Statistical significance is indicated with asterisks for certain Topiramate doses.*

FDA Label Image

Package Label-principal Display Panel (25 mg (60 Tablets Bottle))

Label for Topiramate Tablets, USP 25 mg oral tablets by Exelan Pharmaceuticals Inc. The label indicates a quantity of 1000 tablets with NDC 76282-278-10. It includes storage instructions, manufacturer and distributor information, and a barcode.*

FDA Label Image

Package Label-principal Display Panel (50 mg (60 Tablets Bottle))

Topiramate Tablets, USP 50 mg oral tablets label from Exelan Pharmaceuticals Inc. The label includes the NDC 76282-279-10, a 1000-tablet count, pharmacist dispensing instructions, storage temperature, and manufacturer information for InvaGen Pharmaceuticals and Exelan Pharmaceuticals. The label also shows a barcode and a QR code.*

FDA Label Image

Package Label-principal Display Panel (100 mg (60 Tablets Bottle))

Label for Topiramate Tablets, USP 100 mg oral tablets by Exelan Pharmaceuticals, Inc. The label indicates the product is Rx only and the package contains 1000 tablets. The label displays storage instructions (20° to 25°C) and manufacturer details, including InvaGen Pharmaceuticals, Inc. as manufacturer and Exelan Pharmaceuticals, Inc. as labeler. The NDC number 76282-280-10 is shown.*

FDA Label Image

Package Label-principal Display Panel (200 mg (60 Tablets Bottle))

Topiramate Tablets, USP 200 mg oral tablets label by Exelan Pharmaceuticals, Inc. The label includes the NDC 76282-281-10, states the quantity as 1000 tablets, and notes storage at 20 to 25°C. It indicates manufacturer information: InvaGen Pharmaceuticals, a Cipla Ltd. subsidiary, and manufacturing for Exelan Pharmaceuticals in Boca Raton, FL.*

FDA Label Image

Chemical Structure (Topiramate Str)

Chemical structure of the active ingredient Topiramate, depicting its molecular arrangement including carbon, oxygen, sulfur, nitrogen, and hydrogen atoms in a ring and side groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.